Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2025
2024
2023
2022
2021
2020
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2014
Home
2014
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Change of Director’s Interest Notice – Maria Halasz
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Appendix 4C – quarterly
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Chinese Distribution Agreement Signed for Hair Loss Products
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
USA RNA/DNA Patent for Surgical Adhesion Allowed
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Cleansing Notice and Appendix 3B
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Appendix 4D and Half Year Report
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Cellmid News
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Presentation to the Market
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Cellmid Signs Mk Tribody Collaboration Agreement
1
2
3
4
Next page
